Consulting Services
Compare Stocks
5 / 10Stock Comparison
FCN vs HUBB vs ETN vs HLI vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Industrial - Machinery
Financial - Capital Markets
Industrial - Machinery
FCN vs HUBB vs ETN vs HLI vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Consulting Services | Electrical Equipment & Parts | Industrial - Machinery | Financial - Capital Markets | Industrial - Machinery |
| Market Cap | $4.87B | $26.21B | $155.02B | $10.71B | $79.02B |
| Revenue (TTM) | $3.87B | $6.00B | $28.52B | $2.39B | $18.32B |
| Net Income (TTM) | $267M | $906M | $3.99B | $448M | $2.44B |
| Gross Margin | 31.8% | 35.5% | 36.9% | 38.5% | 52.7% |
| Operating Margin | 10.2% | 20.8% | 18.1% | 21.0% | 19.8% |
| Forward P/E | 17.3x | 25.0x | 30.0x | 19.9x | 21.7x |
| Total Debt | $590M | $2.61B | $11.17B | $438M | $13.76B |
| Cash & Equiv. | $265M | $483M | $622M | $971M | $1.54B |
FCN vs HUBB vs ETN vs HLI vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| FTI Consulting, Inc. (FCN) | 100 | 134.4 | +34.4% |
| Hubbell Incorporated (HUBB) | 100 | 402.8 | +302.8% |
| Eaton Corporation p… (ETN) | 100 | 470.2 | +370.2% |
| Houlihan Lokey, Inc. (HLI) | 100 | 253.7 | +153.7% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FCN vs HUBB vs ETN vs HLI vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FCN is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.09, Low D/E 34.0%, current ratio 1.56x
- Lower P/E (17.3x vs 21.7x), PEG 2.23 vs 4.81
- Beta 0.09 vs EMR's 1.52, lower leverage
HUBB ranks third and is worth considering specifically for valuation efficiency.
- PEG 1.20 vs EMR's 4.81
- +41.5% vs HLI's -5.1%
ETN is the clearest fit if your priority is long-term compounding.
- 6.1% 10Y total return vs HLI's 6.0%
HLI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 7 yrs, beta 0.94, yield 1.6%
- Rev growth 24.8%, EPS growth 41.6%
- Beta 0.94, yield 1.6%, current ratio 1.38x
- 24.8% NII/revenue growth vs FCN's 2.4%
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 24.8% NII/revenue growth vs FCN's 2.4% | |
| Value | Lower P/E (17.3x vs 21.7x), PEG 2.23 vs 4.81 | |
| Quality / Margins | 16.7% margin vs FCN's 6.9% | |
| Stability / Safety | Beta 0.09 vs EMR's 1.52, lower leverage | |
| Dividends | 1.6% yield, 7-year raise streak, vs EMR's 1.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +41.5% vs HLI's -5.1% | |
| Efficiency (ROA) | 11.9% ROA vs EMR's 5.8%, ROIC 15.5% vs 8.2% |
FCN vs HUBB vs ETN vs HLI vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FCN vs HUBB vs ETN vs HLI vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HLI leads in 2 of 6 categories
FCN leads 1 • ETN leads 1 • HUBB leads 0 • EMR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HLI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ETN is the larger business by revenue, generating $28.5B annually — 11.9x HLI's $2.4B. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to FCN's 6.9%. On growth, ETN holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.9B | $6.0B | $28.5B | $2.4B | $18.3B |
| EBITDAEarnings before interest/tax | $445M | $1.5B | $5.9B | $591M | $4.7B |
| Net IncomeAfter-tax profit | $267M | $906M | $4.0B | $448M | $2.4B |
| Free Cash FlowCash after capex | $318M | $909M | $4.7B | $739M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +31.8% | +35.5% | +36.9% | +38.5% | +52.7% |
| Operating MarginEBIT ÷ Revenue | +10.2% | +20.8% | +18.1% | +21.0% | +19.8% |
| Net MarginNet income ÷ Revenue | +6.9% | +15.1% | +14.0% | +16.7% | +13.3% |
| FCF MarginFCF ÷ Revenue | +8.2% | +15.2% | +16.5% | +33.9% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.5% | +11.1% | +16.8% | — | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.0% | +8.3% | -9.4% | +22.3% | +28.2% |
Valuation Metrics
FCN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 19.6x trailing earnings, FCN trades at a 49% valuation discount to ETN's 38.2x P/E. Adjusting for growth (PEG ratio), HUBB offers better value at 1.43x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.9B | $26.2B | $155.0B | $10.7B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $28.3B | $165.6B | $10.2B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | 19.64x | 29.81x | 38.17x | 26.37x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.32x | 25.01x | 30.00x | 19.92x | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | 2.53x | 1.43x | 1.55x | 1.67x | 7.73x |
| EV / EBITDAEnterprise value multiple | 11.21x | 20.81x | 27.69x | 18.75x | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 1.29x | 4.48x | 5.65x | 4.48x | 4.39x |
| Price / BookPrice ÷ Book value/share | 3.07x | 6.85x | 7.99x | 4.84x | 3.94x |
| Price / FCFMarket cap ÷ FCF | 31.13x | 29.97x | 34.67x | 13.24x | 29.63x |
Profitability & Efficiency
HLI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HUBB delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $12 for EMR. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x. On the Piotroski fundamental quality scale (0–9), HUBB scores 7/9 vs FCN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.1% | +24.4% | +20.8% | +20.1% | +12.1% |
| ROA (TTM)Return on assets | +7.6% | +11.6% | +9.0% | +11.9% | +5.8% |
| ROICReturn on invested capital | +15.9% | +17.1% | +13.6% | +15.5% | +8.2% |
| ROCEReturn on capital employed | +16.0% | +20.1% | +16.8% | +20.1% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.34x | 0.68x | 0.57x | 0.20x | 0.68x |
| Net DebtTotal debt minus cash | $324M | $2.1B | $10.5B | -$533M | $12.2B |
| Cash & Equiv.Liquid assets | $265M | $483M | $622M | $971M | $1.5B |
| Total DebtShort + long-term debt | $590M | $2.6B | $11.2B | $438M | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 28.20x | 16.90x | 16.38x | — | 6.46x |
Total Returns (Dividends Reinvested)
ETN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ETN five years ago would be worth $28,282 today (with dividends reinvested), compared to $11,256 for FCN. Over the past 12 months, HUBB leads with a +41.5% total return vs HLI's -5.1%. The 3-year compound annual growth rate (CAGR) favors ETN at 34.1% vs FCN's -2.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.0% | +6.8% | +22.3% | -12.6% | +4.3% |
| 1-Year ReturnPast 12 months | -2.0% | +41.5% | +33.2% | -5.1% | +30.4% |
| 3-Year ReturnCumulative with dividends | -8.2% | +87.9% | +141.3% | +85.7% | +75.9% |
| 5-Year ReturnCumulative with dividends | +12.6% | +159.4% | +182.8% | +141.5% | +59.5% |
| 10-Year ReturnCumulative with dividends | +294.4% | +410.7% | +608.7% | +603.4% | +206.6% |
| CAGR (3Y)Annualised 3-year return | -2.8% | +23.4% | +34.1% | +22.9% | +20.7% |
Risk & Volatility
Evenly matched — FCN and ETN each lead in 1 of 2 comparable metrics.
Risk & Volatility
FCN is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ETN currently trades 91.7% from its 52-week high vs HLI's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.09x | 1.38x | 1.42x | 0.94x | 1.52x |
| 52-Week HighHighest price in past year | $189.30 | $565.50 | $435.43 | $211.78 | $165.15 |
| 52-Week LowLowest price in past year | $149.31 | $349.40 | $296.93 | $134.41 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +85.5% | +87.2% | +91.7% | +72.5% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 28.1 | 41.2 | 59.8 | 36.6 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 426K | 546K | 2.5M | 606K | 2.8M |
Analyst Outlook
Evenly matched — HLI and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FCN as "Buy", HUBB as "Hold", ETN as "Buy", HLI as "Buy", EMR as "Buy". Consensus price targets imply 30.3% upside for HLI (target: $200) vs -4.9% for ETN (target: $380). For income investors, HLI offers the higher dividend yield at 1.57% vs ETN's 1.05%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $166.00 | $535.14 | $379.78 | $200.00 | $161.92 |
| # AnalystsCovering analysts | 13 | 17 | 39 | 15 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% | +1.0% | +1.6% | +1.5% |
| Dividend StreakConsecutive years of raises | 0 | 12 | 24 | 7 | 37 |
| Dividend / ShareAnnual DPS | — | $5.35 | $4.17 | $2.41 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +17.6% | +0.9% | +1.2% | +0.5% | +1.6% |
HLI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FCN leads in 1 (Valuation Metrics). 2 tied.
FCN vs HUBB vs ETN vs HLI vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FCN or HUBB or ETN or HLI or EMR a better buy right now?
For growth investors, Houlihan Lokey, Inc.
(HLI) is the stronger pick with 24. 8% revenue growth year-over-year, versus 2. 4% for FTI Consulting, Inc. (FCN). FTI Consulting, Inc. (FCN) offers the better valuation at 19. 6x trailing P/E (17. 3x forward), making it the more compelling value choice. Analysts rate FTI Consulting, Inc. (FCN) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FCN or HUBB or ETN or HLI or EMR?
On trailing P/E, FTI Consulting, Inc.
(FCN) is the cheapest at 19. 6x versus Eaton Corporation plc at 38. 2x. On forward P/E, FTI Consulting, Inc. is actually cheaper at 17. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Hubbell Incorporated wins at 1. 20x versus Emerson Electric Co. 's 4. 81x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — FCN or HUBB or ETN or HLI or EMR?
Over the past 5 years, Eaton Corporation plc (ETN) delivered a total return of +182.
8%, compared to +12. 6% for FTI Consulting, Inc. (FCN). Over 10 years, the gap is even starker: ETN returned +608. 7% versus EMR's +206. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FCN or HUBB or ETN or HLI or EMR?
By beta (market sensitivity over 5 years), FTI Consulting, Inc.
(FCN) is the lower-risk stock at 0. 09β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 1601% more volatile than FCN relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — FCN or HUBB or ETN or HLI or EMR?
By revenue growth (latest reported year), Houlihan Lokey, Inc.
(HLI) is pulling ahead at 24. 8% versus 2. 4% for FTI Consulting, Inc. (FCN). On earnings-per-share growth, the picture is similar: Houlihan Lokey, Inc. grew EPS 41. 6% year-over-year, compared to 5. 5% for FTI Consulting, Inc.. Over a 3-year CAGR, ETN leads at 9. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FCN or HUBB or ETN or HLI or EMR?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus 7. 1% for FTI Consulting, Inc. — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21. 0% versus 10. 9% for FCN. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FCN or HUBB or ETN or HLI or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Hubbell Incorporated (HUBB) is the more undervalued stock at a PEG of 1. 20x versus Emerson Electric Co. 's 4. 81x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, FTI Consulting, Inc. (FCN) trades at 17. 3x forward P/E versus 30. 0x for Eaton Corporation plc — 12. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 30. 3% to $200. 00.
08Which pays a better dividend — FCN or HUBB or ETN or HLI or EMR?
In this comparison, HLI (1.
6% yield), EMR (1. 5% yield), HUBB (1. 1% yield), ETN (1. 0% yield) pay a dividend. FCN does not pay a meaningful dividend and should not be held primarily for income.
09Is FCN or HUBB or ETN or HLI or EMR better for a retirement portfolio?
For long-horizon retirement investors, FTI Consulting, Inc.
(FCN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 09), +294. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FCN: +294. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FCN and HUBB and ETN and HLI and EMR?
These companies operate in different sectors (FCN (Industrials) and HUBB (Industrials) and ETN (Industrials) and HLI (Financial Services) and EMR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FCN is a small-cap quality compounder stock; HUBB is a mid-cap quality compounder stock; ETN is a mid-cap quality compounder stock; HLI is a mid-cap high-growth stock; EMR is a mid-cap quality compounder stock. HUBB, ETN, HLI, EMR pay a dividend while FCN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.